Publikationen in Zusammenarbeit mit Forschern von Centre National de la Recherche Scientifique (32)

2023

  1. Corrigendum to “Lithocholic acid-based design of noncalcemic vitamin D receptor agonists” [Bioorg. Chem. 111 (2021) 104878] (Bioorganic Chemistry (2021) 111, (S0045206821002558), (10.1016/j.bioorg.2021.104878))

    Bioorganic Chemistry

2022

  1. Advances in Vitamin D Receptor Function and Evolution Based on the 3D Structure of the Lamprey Ligand-Binding Domain

    Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5821-5829

  2. On-surface synthesis of Mn-phthalocyanines with optically active ligands

    Nanoscale, Vol. 14, Núm. 22, pp. 8069-8077

  3. Reaction of OH radicals with CH3NH2 in the gas phase: experimental (11.7-177.5 K) and computed rate coefficients (10-1000 K)

    Physical chemistry chemical physics : PCCP, Vol. 24, Núm. 38, pp. 23593-23601

2021

  1. Design, Synthesis, Evaluation and Structure of Allenic 1α,25-Dihydroxyvitamin D3 Analogs with Locked Mobility at C-17

    Chemistry - A European Journal, Vol. 27, Núm. 53, pp. 13384-13389

  2. Design, synthesis and evaluation of side-chain hydroxylated derivatives of lithocholic acid as potent agonists of the vitamin D receptor (VDR)

    Bioorganic Chemistry, Vol. 115

  3. Lithocholic acid-based design of noncalcemic vitamin D receptor agonists

    Bioorganic Chemistry, Vol. 111

2019

  1. L -Cysteine Modified by S-Sulfation: Consequence on Fragmentation Processes Elucidated by Tandem Mass Spectrometry and Chemical Dynamics Simulations

    Journal of Physical Chemistry A, Vol. 123, Núm. 17, pp. 3685-3696

2015

  1. Integration of functional complex oxide nanomaterials on silicon

    Frontiers in Physics, Vol. 3, Núm. JUN

2013

  1. Dynamic amphiphile libraries to screen for the "fragrant" delivery of siRNA into HeLa cells and human primary fibroblasts

    Journal of the American Chemical Society, Vol. 135, Núm. 25, pp. 9295-9298

2011

  1. 1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: Its synthesis, biological activity and crystal structure with its receptor

    PLoS ONE, Vol. 6, Núm. 3

  2. Synthesis, structure, and biological activity of des-side Chain analogues of 1α,25-Dihydroxyvitamin D3 with substituents at C18

    ChemMedChem, Vol. 6, Núm. 5, pp. 788-793

2008

  1. Crystal structure of the avian reovirus inner capsid protein σA

    Journal of Virology, Vol. 82, Núm. 22, pp. 11208-11216

  2. First interlaboratory exercise on non-steroidal anti-inflammatory drugs analysis in environmental samples

    Talanta, Vol. 76, Núm. 3, pp. 580-590

  3. Structure-Based Design of a Superagonist Ligand for the Vitamin D Nuclear Receptor

    Chemistry and Biology, Vol. 15, Núm. 4, pp. 383-392

2007

  1. Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol

    Archives of Biochemistry and Biophysics, Vol. 460, Núm. 2, pp. 172-176

2006

  1. Novel peroxidase mimics: μ-Aqua manganese-Schiff base dimers

    Journal of Inorganic Biochemistry, Vol. 100, Núm. 9, pp. 1470-1478

2005

  1. Electrochemical synthesis of MII complexes with a schiff base containing an amido group. Crystal structure of a cobalt(II) complex with a reorganised ligand

    Zeitschrift fur Anorganische und Allgemeine Chemie

2003

  1. Argon broadening of the 13CO R(0) and R(7) transitions in the fundamental band at temperatures between 80 and 297 K: Comparison between experiment and theory

    Journal of Molecular Spectroscopy, Vol. 222, Núm. 2, pp. 131-141

2001

  1. Spontaneous magnetostriction in la2/3(Ca1-x Sr x) 1/3MnO3 (x = 0, 0.05, 0.15, 0.25 and 1.0) near Tcand its field dependence

    Journal of Magnetism and Magnetic Materials, Vol. 226-230, Núm. PART I, pp. 582-584